The principal findings of this study are that plasma Nt-proBNP levels are lower in CHF patients with metabolic syndrome attributable to inverse relationships between plasma Nt-proBNP and BMI, plasma triglyceride and insulin resistance (HOMA-IR). Here, NPPB is linked to congestive heart failure.